Evidence map›Paper›PMID 25185265›Full record

ArticleBlood2014

UBAP2L is a novel BMI1-interacting protein essential for hematopoietic stem cell activity.

Marie-Eve Bordeleau, Romain Aucagne, Jalila Chagraoui, Simon Girard, Nadine Mayotte, Eric Bonneil, Pierre Thibault, Caroline Pabst, Anne Bergeron, Frédéric Barabé and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Powerful mapping ofmedRxiv : the preprint server for health sciences · 2024
    Article
  4. Article
  5. Three-dimensional microCT imaging of mouse heart development from early post-implantation to late fetal stages.Mammalian genome : official journal of the International Mammalian Genome Society · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Ubiquitin Binding Protein 2-Like (UBAP2L): is it so NICE After All?Frontiers in cell and developmental biology · 2022
    Review
  11. Article
  12. BMI1 enables extensive expansion of functional erythroblasts from human peripheral blood mononuclear cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2021
    Article
  13. Gender-specific SBNO2 and VPS13B as a potential driver of osteoporosis development in male ankylosing spondylitis.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2021
    Article
  14. Article
  15. Article
  16. Article
  17. DHHC protein family targets different subsets of glioma stem cells in specific niches.Journal of experimental & clinical cancer research : CR · 2019
    Article
  18. Article
  19. Knockdown of Ubiquitin Associated Protein 2-Like (UBAP2L) Inhibits Growth and Metastasis of Hepatocellular Carcinoma.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 5 institutions in 1 country.

Marie-Eve BordeleauInstitute for Research in Immunology and Cancer and.
Romain AucagneInstitute for Research in Immunology and Cancer and.
Jalila ChagraouiInstitute for Research in Immunology and Cancer and.
Simon GirardInstitute for Research in Immunology and Cancer and.
Nadine MayotteInstitute for Research in Immunology and Cancer and.
Eric BonneilInstitute for Research in Immunology and Cancer and.
Pierre ThibaultInstitute for Research in Immunology and Cancer and Departments of Biochemistry and Chemistry, Université de Montréal, Montréal, QC, Canada;
Caroline PabstInstitute for Research in Immunology and Cancer and.
Anne BergeronCentre Hospitalier Universitaire de Québec, Centre de Recherche du Centre Hospitalier de l'Université Laval and Hôpital de l'Enfant-Jésus, Quebec City, QC, Canada;
Frédéric BarabéCentre Hospitalier Universitaire de Québec, Centre de Recherche du Centre Hospitalier de l'Université Laval and Hôpital de l'Enfant-Jésus, Quebec City, QC, Canada; Department of Medicine, Université Laval, Quebec City, QC, Canada;
Josée HébertDivision of Hematology and Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada; and.
Martin SauvageauInstitute for Research in Immunology and Cancer and.
Christel BoutonnetInstitute for Research in Immunology and Cancer and.
Sylvain MelocheInstitute for Research in Immunology and Cancer and Department of Pharmacology and.
Guy SauvageauInstitute for Research in Immunology and Cancer and Division of Hematology and Leukemia Cell Bank of Quebec, Maisonneuve-Rosemont Hospital, Montréal, QC, Canada; and Department of Medicine, Université de Montréal, Montréal, QC, Canada.
Institute for Research in Immunology and Cancer · CACentre hospitalier universitaire de Québec · CAHôpital de l'Enfant-Jésus · CAHôpital Maisonneuve-Rosemont · CAUniversité de Montréal · CA

Funding

Canadian Institutes of Health Research MOP 14168Canadian Institutes of Health Research MOP 15064
6 · The paper itself

Abstract

Multipotent long-term repopulating hematopoietic stem cells (LT-HSCs) can self-renew or differentiate into the less primitive short-term repopulating stem cells (ST-HSCs), which themselves produce progenitors that ensure the daily supply of all essential blood components. The Polycomb group (PcG) protein BMI1 is essential for the activity of both HSCs and progenitor cells. Although BMI1 operates by suppressing the Ink4a/Arf locus in progenitors and ST-HSCs, the mechanisms through which this gene regulates the activity of LT-HSCs remain poorly understood. Toward this goal, we isolated BMI1-containing protein complexes and identified UBAP2L as a novel BMI1-interacting protein. We also showed that UBAP2L is preferentially expressed in mouse and human HSC-enriched populations when compared with more mature cell types, and that this gene is essential for the activity of LT-HSCs. In contrast to what is observed for Bmi1 knockdown, we found that UBAP2L depletion does not affect the Ink4a/Arf locus. Given that we demonstrated that BMI1 overexpression is able to rescue the deleterious effects of Ubap2l downregulation on LT-HSC activity and that UBAP2L is part of a PcG subcomplex comprising BMI1, we propose a model in which at least 2 different BMI1-containing PcG complexes regulate HSC activity, which are distinguishable by the presence of UBAP2L.

Indexed as

AnimalsBone Marrow CellsCarrier ProteinsCyclin-Dependent Kinase Inhibitor p16Down-RegulationGene DeletionGene Knockdown TechniquesHEK293 CellsHematopoietic Stem CellsHumansLeukemia, Myeloid, AcuteMice, Inbred C57BLPolycomb-Group ProteinsPolycomb Repressive Complex 1Protein BindingProto-Oncogene ProteinsBMI1 protein, humanBmi1 protein, mouseCarrier ProteinsCyclin-Dependent Kinase Inhibitor p16Polycomb-Group ProteinsPolycomb Repressive Complex 1Proto-Oncogene ProteinsRNA, Small InterferingRnf2 protein, mouseUbap2L protein, humanUbap2L protein, mouseUbiquitin-Protein Ligases

Identifiers

PMID25185265
PMCPMC4192749
OpenAlexW2045271912

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.